首页 > 市场调查报告书 > 医疗设备

生技设备

生物晶片市场规模、份额和成长分析（按类型、製造技术、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902279

生物晶片市场规模、份额和成长分析（按类型、製造技术、应用、最终用户和地区划分）－2026-2033年产业预测

Biochip Market Size, Share, and Growth Analysis, By Type (DNA Chips, Lab-On-A-Chip), By Fabrication Technology (Microarrays, Microfluidics), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，生物晶片市场规模将达到 121 亿美元，到 2025 年将达到 136.3 亿美元，到 2033 年将达到 354.3 亿美元，在预测期（2026-2033 年）内，复合年增长率为 12.68%。

生物晶片市场正经历显着成长，这主要得益于对先进诊断解决方案和就地检验需求的不断增长。慢性病发病率的上升以及蛋白质组学和基因组学在癌症研究中的应用进一步推动了这一增长。主要企业正致力于开发创新诊断测试，以因应慢性病（尤其是老年族群）日益增长的趋势。由于实验室晶片系统能够有效诊断慢性病，因此其需求不断增长。生物晶片因其样本消费量低、能够高效进行全蛋白质组分析（这对生物标记和药物发现至关重要）而在生物医学和倡议领域日益受到关注。此外，新产品的不断涌入也显着促进了市场的扩张。

生物晶片市场驱动因素

基因组学和蛋白质组学的最新进展显着影响着生物晶片市场，这些进展使我们对个体基因谱和疾病的潜在机制有了更深入的了解。这些知识的累积催生了对精准个人化医疗的需求。生物晶片是该领域不可或缺的工具，因为它们能够快速有效地分析大量资料集，并有助于识别与各种健康状况相关的特定基因突变和生物标记。向个人化医疗的转变正在改善患者的治疗效果，从而加速了生物晶片在临床环境中的整合和应用，进而推动了市场成长。

生物晶片市场的限制因素

生物晶片市场面临许多限制因素，主要在于开发先进生物晶片以确保其准确性和可靠性需要耗费大量成本和漫长的研发过程。将这些生物晶片整合到现有的医疗保健系统和检查室基础设施中需要大量的资金投入，这阻碍了许多医疗机构的广泛采用。此外，持续的维护成本也增加了复杂性。儘管存在这些挑战，但随着时间的推移，技术进步和规模经济的不断扩大有望减轻这些经济负担，从而促进生物晶片在各种医疗保健环境中的普及和应用。

生物晶片市场趋势

随着相关人员日益重视根据个人基因谱量身定制的治疗方案，生物晶片市场正呈现出向个人化医疗和精准诊断方向发展的显着趋势。基因组学和蛋白质组学的持续进步推动了这一需求，而生物晶片凭藉其处理海量基因数据和揭示蛋白质相互作用的能力，正处于这一领域的前沿。生物晶片与人工智慧和机器学习等先进技术的融合，不仅增强了其诊断能力，还催生了用于精准疾病识别和治疗的创新工具。这种融合不仅提高了基因突变和生物标记检测的准确性，也加速了个人化医疗解决方案的演进。

DNA晶片
- 基因表现
- SNP基因基因型鉴定
- 癌症诊断和治疗
- 基因组学
- 药物发现
- 农业生物技术
- 其他DNA晶片应用
晶片实验室
- 临床诊断
- 基因组学
- 体外诊断和即时检测
- 蛋白质体学
- 药物发现
- 其他 LoAC 应用
蛋白质晶片
- 蛋白质体学
- 表达谱分析
- 诊断
- 高通量筛检
- 药物发现
- 其他蛋白质晶片应用
其他数组
- 细胞阵列
- 组织阵列

生物晶片市场，依製造技术划分

微阵列
微流体技术

生物晶片市场，依应用领域划分

基因组学
药物研发
农业
其他的

生物晶片市场，依最终用户划分

生物技术和製药公司
医院和诊断中心
学术和研究机构
其他最终用户

生物晶片市场规模：（按地区划分）

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Abbott Laboratories
Agilent Technologies, Inc.
PerkinElmer, Inc.
Standard BioTools Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Micronit Microtechnologies
Randox Laboratories Ltd.
RayBiotech, Inc.
Invitae
CapitalBio Corporation
Genscript Biotech Corp
Takara Bio Usa Holdings, Inc.

简介目录

Product Code: SQMIG45A2235

Biochip Market size was valued at USD 12.1 Billion in 2024 and is poised to grow from USD 13.63 Billion in 2025 to USD 35.43 Billion by 2033, growing at a CAGR of 12.68% during the forecast period (2026-2033).

The biochip market is witnessing substantial growth driven by increased demand for advanced diagnostic solutions and point-of-care testing. The rise of chronic diseases and the application of proteomics and genomics in cancer research further fuel this growth. Major players are focusing on developing innovative diagnostic tests, aligning with the growing prevalence of chronic conditions, particularly among the elderly. The demand for lab-on-a-chip systems is expanding as they facilitate effective diagnosis of chronic illnesses. Biochips are gaining traction in biomedical and biotechnological fields due to their low sample consumption and efficiency in proteome-wide analyses, which are vital for biomarker and drug discovery initiatives. Additionally, the introduction of novel products in the market has significantly impacted its expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biochip market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biochip Market Segments Analysis

Global Biochips Market is segmented by Type, Fabrication Technology, Application, End User, and Region. Based on Type, the market is segmented into DNA Chips (Gene Expression, SNP Genotyping, Cancer Diagnosis & Treatment, Genomics, Drug Discovery, Agricultural Biotechnology, Other DNA Chip Applications), Lab-On-A-Chip (Clinical Diagnostics, Genomics, IVD & POC, Proteomics, Drug Discovery, Other Loac Applications), Protein Chips (Proteomics, Expression Profiling, Diagnostics, High-Throughput Screening, Drug Discovery, Other Protein Chip Applications), Other Arrays (Cell Arrays, Tissue Arrays). Based on Fabrication Technology, the market is segmented into Microarrays, Microfluidics. Based on Application, the market is segmented into Genomics, Drug Development, Agriculture, and Others. Based on End User, the market is segmented into Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biochip Market

The biochip market is significantly influenced by recent advancements in genomics and proteomics, which enhance our understanding of individual genetic profiles and the underlying mechanisms of diseases. This growing knowledge creates a demand for precise and personalized medical treatments. Biochips are essential tools in this landscape, as they enable rapid and efficient analysis of extensive datasets, helping to identify specific genetic mutations and biomarkers linked to various health conditions. The shift towards personalized medicine is improving patient outcomes, subsequently accelerating the integration and use of biochips in clinical environments, thereby driving market growth.

Restraints in the Biochip Market

The biochip market faces several restraints primarily due to the substantial costs and lengthy processes associated with developing advanced biochips that guarantee accuracy and reliability. Integrating these biochips into current healthcare systems and laboratory infrastructures demands significant financial investments, which can be a hurdle for many healthcare facilities, hampering widespread adoption. Moreover, the ongoing maintenance costs add another layer of complexity. Despite these challenges, advancements in technology and increased economies of scale are anticipated to ease these financial burdens over time, potentially fostering greater acceptance and integration of biochips in various healthcare contexts.

Market Trends of the Biochip Market

The biochip market is experiencing a notable trend towards personalized medicine and precision diagnostics, as stakeholders increasingly prioritize treatments tailored to individual genetic profiles. The continued advancements in genomics and proteomics are fueling this demand, with biochips at the forefront due to their capacity to process extensive genetic data and elucidate protein interactions. The convergence of biochips with advanced technologies like artificial intelligence and machine learning enhances their diagnostic capabilities, leading to the development of innovative tools for precise disease identification and treatment. This alignment not only improves accuracy in detecting genetic mutations and biomarkers but also accelerates the evolution of personalized healthcare solutions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Technology Analysis
Patent Analysis
Regulatory Landscape
PESTEL Analysis

Biochips Market, By Type

Market Overview
DNA Chips
- Gene Expression
- SNP Genotyping
- Cancer Diagnosis & Treatment
- Genomics
- Drug Discovery
- Agricultural Biotechnology
- Other DNA Chip Applications
Lab-On-A-Chip
- Clinical Diagnostics
- Genomics
- IVD & POC
- Proteomics
- Drug Discovery
- Other Loac Applications
Protein Chips
- Proteomics
- Expression Profiling
- Diagnostics
- High-Throughput Screening
- Drug Discovery
- Other Protein Chip Applications
Other Arrays
- Cell Arrays
- Tissue Arrays

Biochips Market, By Fabrication Technology

Market Overview
Microarrays
Microfluidics

Biochips Market, By Application

Market Overview
Genomics
Drug Development
Agriculture
Others

Biochips Market, By End User

Market Overview
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Other End Users

Biochips Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micronit Microtechnologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayBiotech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapitalBio Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Usa Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments